4//SEC Filing
Palleiko Benjamin L 4
Accession 0001366244-25-000007
CIK 0001348911other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 6:16 PM ET
Size
9.5 KB
Accession
0001366244-25-000007
Insider Transaction Report
Form 4
Palleiko Benjamin L
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-12-06+15,625→ 431,814 total - Sale
Common Stock
2025-12-08$16.51/sh−7,294$120,424→ 424,520 total - Exercise/Conversion
Restricted Stock Unit
2025-12-06−15,625→ 140,626 total→ Common Stock (15,625 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on June 6, 2024, subject to continued service through each vesting date.
Documents
Issuer
KalVista Pharmaceuticals, Inc.
CIK 0001348911
Entity typeother
Related Parties
1- filerCIK 0001366244
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 6:16 PM ET
- Size
- 9.5 KB